Botox-A induced apoptosis and suppressed cell proliferation in fibroblasts pre-treated with breast cancer exosomes.
Abstract
[BACKGROUND] breast cancer-associated fibroblast (CAF) is linked to metastasis and is poor for breast cancer prognosis. Since Clostridium Toxin A (Botox-A) had represented a cytotoxic effect on fibroblasts, this study aims to assess Botox-A cytotoxicity in both normal fibroblasts and exosome-induced CAFs.
[MATERIAL AND METHOD] the serum exosomes of 40 BC patients and 30 healthy individuals were isolated and lncRNA H19 (lnch19) levels were assessed by qRT-PCR method. After that, Breast Cancer (BC) exosomes co-cultured with Human foreskin fibroblasts (HFF) and qRT-PCR were applied to evaluate α-SMA, Vimentin, BCL-2, and BAX expression. Both Normal and malignant HFFs co-cultured with Botox-A, and Botox-A loaded exosome for 24 and 48 h and their apoptosis, Cell proliferation, and viability were monitored by MTT assay, Annexin V-FITC and PI staining and qRT-PCR for BCL-2, BAX, and cyclin D1 mRNAs.
[RESULTS] Serum exosomes of BC patients had significantly higher levels of lncRNA H19 than healthy individuals. MTT assay results showed Botox-A decreased vital Human foreskin fibroblasts in a dose-dependent manner. BC exosomes significantly increased α-SMA, Vimentin, and BCL-2 mRNA levels in Human foreskin fibroblasts, on the other hand, BAX decreased meaningfully. Co-culture of exosome-treated HFF cells with both Botox-A and Botox-A loaded exosomes significantly boosted BCL-2 mRNA levels, completely contrary to BAX and cyclid d1 expression. Meanwhile, flow cytometry results confirmed a high rate of apoptosis in malignant Human foreskin fibroblasts treated with Botox-A loaded exosome.
[CONCLUSION] The findings of this study indicate that exosomal lncRNA H19 could be a diagnostic marker for Breast Cancer and these Breast cancer exosomes can induce malignant phenotype in fibroblasts and turn them into CAFs. Botox-A could be toxic for both normal fibroblasts and CAFs, inducing apoptosis and suppressing cell proliferation among them.
[MATERIAL AND METHOD] the serum exosomes of 40 BC patients and 30 healthy individuals were isolated and lncRNA H19 (lnch19) levels were assessed by qRT-PCR method. After that, Breast Cancer (BC) exosomes co-cultured with Human foreskin fibroblasts (HFF) and qRT-PCR were applied to evaluate α-SMA, Vimentin, BCL-2, and BAX expression. Both Normal and malignant HFFs co-cultured with Botox-A, and Botox-A loaded exosome for 24 and 48 h and their apoptosis, Cell proliferation, and viability were monitored by MTT assay, Annexin V-FITC and PI staining and qRT-PCR for BCL-2, BAX, and cyclin D1 mRNAs.
[RESULTS] Serum exosomes of BC patients had significantly higher levels of lncRNA H19 than healthy individuals. MTT assay results showed Botox-A decreased vital Human foreskin fibroblasts in a dose-dependent manner. BC exosomes significantly increased α-SMA, Vimentin, and BCL-2 mRNA levels in Human foreskin fibroblasts, on the other hand, BAX decreased meaningfully. Co-culture of exosome-treated HFF cells with both Botox-A and Botox-A loaded exosomes significantly boosted BCL-2 mRNA levels, completely contrary to BAX and cyclid d1 expression. Meanwhile, flow cytometry results confirmed a high rate of apoptosis in malignant Human foreskin fibroblasts treated with Botox-A loaded exosome.
[CONCLUSION] The findings of this study indicate that exosomal lncRNA H19 could be a diagnostic marker for Breast Cancer and these Breast cancer exosomes can induce malignant phenotype in fibroblasts and turn them into CAFs. Botox-A could be toxic for both normal fibroblasts and CAFs, inducing apoptosis and suppressing cell proliferation among them.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botox
|
보툴리눔독소 주사 | dict | 10 | |
| 해부 | breast
|
유방 | dict | 6 | |
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | fibroblasts
|
scispacy | 1 | ||
| 해부 | serum exosomes
|
scispacy | 1 | ||
| 해부 | HFF
→ Human foreskin fibroblasts
|
scispacy | 1 | ||
| 해부 | malignant HFFs
|
scispacy | 1 | ||
| 해부 | exosome
|
scispacy | 1 | ||
| 해부 | exosome-treated HFF cells
|
scispacy | 1 | ||
| 해부 | exosomes
|
scispacy | 1 | ||
| 해부 | exosomal
|
scispacy | 1 | ||
| 약물 | Clostridium Toxin A
|
scispacy | 1 | ||
| 약물 | Annexin V-FITC
|
C1528365
FITC-annexin A5
|
scispacy | 1 | |
| 약물 | [BACKGROUND] breast cancer-associated fibroblast
|
scispacy | 1 | ||
| 약물 | Botox-A
→ breast cancer prognosis. Since Clostridium Toxin A
|
scispacy | 1 | ||
| 약물 | [MATERIAL AND
|
scispacy | 1 | ||
| 질환 | breast cancer
|
C0006142
Malignant neoplasm of breast
|
scispacy | 1 | |
| 질환 | CAF
→ cancer-associated fibroblast
|
scispacy | 1 | ||
| 질환 | CAFs
|
scispacy | 1 | ||
| 질환 | BC patients
|
scispacy | 1 | ||
| 질환 | BC exosomes
|
scispacy | 1 | ||
| 질환 | malignant Human foreskin fibroblasts
|
scispacy | 1 | ||
| 질환 | Breast cancer exosomes
|
scispacy | 1 | ||
| 기타 | Botox-A
→ breast cancer prognosis. Since Clostridium Toxin A
|
scispacy | 1 | ||
| 기타 | Clostridium Toxin A
|
scispacy | 1 | ||
| 기타 | H19
|
scispacy | 1 | ||
| 기타 | Human foreskin fibroblasts
|
scispacy | 1 | ||
| 기타 | Vimentin
|
scispacy | 1 | ||
| 기타 | BCL-2
|
scispacy | 1 | ||
| 기타 | BAX
|
scispacy | 1 | ||
| 기타 | Annexin V-FITC
|
scispacy | 1 | ||
| 기타 | cyclin D1
|
scispacy | 1 |
MeSH Terms
Humans; Exosomes; Apoptosis; Cell Proliferation; Female; Botulinum Toxins, Type A; Breast Neoplasms; RNA, Long Noncoding; Fibroblasts; Male; bcl-2-Associated X Protein; Middle Aged; Cancer-Associated Fibroblasts; Adult; Coculture Techniques; Proto-Oncogene Proteins c-bcl-2
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.